However, other transcription factor(s) that reduce SLC7A1 transcriptional activity, such as the C/EBP homologous protein 10 (CHOP) as reported in C6 rat glioma cells [33], may be involved in mediating insulin effects. The gene discussed is INS; the disease is central nervous system cancer.